相似文献
1
Commentary: Ocular toxoplasma: From bench-side to clinical practice!
Indian J Ophthalmol. 2018 Oct;66(10):1489-1490. doi: 10.4103/ijo.IJO_999_18.
2
Ocular toxoplasmosis in the United States: recent and remote infections.
Clin Infect Dis. 2015 Jan 15;60(2):271-3. doi: 10.1093/cid/ciu793. Epub 2014 Oct 9.
3
Anti-toxoplasma serotitres in ocular toxoplasmosis.
Eye (Lond). 1991;5 ( Pt 5):636-9. doi: 10.1038/eye.1991.110.
4
Association of ocular toxoplasmosis with type I Toxoplasma gondii strains: direct genotyping from peripheral blood samples.
J Clin Microbiol. 2006 Nov;44(11):4262-4. doi: 10.1128/JCM.01786-06. Epub 2006 Sep 27.
5
TGF-β1 levels and intraocular tissue alterations in mice infected with a virulent type I RH Toxoplasma gondii strain.
Exp Parasitol. 2016 Mar;162:57-63. doi: 10.1016/j.exppara.2016.01.003. Epub 2016 Jan 8.
6
Epidemiology, pathophysiology, and the future of ocular toxoplasmosis.
Ocul Immunol Inflamm. 2014 Apr;22(2):138-47. doi: 10.3109/09273948.2013.823214. Epub 2013 Oct 16.
7
[The effect of a subretinal injection of Toxoplasma gondii on the serum antibody titer in a rabbit model of ocular toxoplasmosis].
Angew Parasitol. 1989 Feb;30(1):15-7.
8
Characterization of Toxoplasma gondii-specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis.
Invest Ophthalmol Vis Sci. 2001 Dec;42(13):3228-32.
9
Excretory-secretory antigens: a suitable candidate for immunization against ocular toxoplasmosis in a murine model.
Comp Immunol Microbiol Infect Dis. 2014 Dec;37(5-6):369-74. doi: 10.1016/j.cimid.2014.10.003. Epub 2014 Oct 28.
10
Ocular toxoplasmosis during natalizumab treatment.
Neurology. 2009 Oct 27;73(17):1418-9. doi: 10.1212/WNL.0b013e3181bd114f. Epub 2009 Sep 23.
引用本文的文献
1
Acquired Immunodeficiency Syndrome Presented as Atypical Ocular Toxoplasmosis.
Case Rep Ophthalmol Med. 2021 May 1;2021:5512408. doi: 10.1155/2021/5512408. eCollection 2021.
本文引用的文献
1
Anatomical and functional outcomes of pars plana vitrectomy for inflammatory epiretinal membrane surgery in healed toxoplasmosis infection.
Indian J Ophthalmol. 2018 Oct;66(10):1485-1489. doi: 10.4103/ijo.IJO_364_18.
2
Recent Developments in the Diagnosis and Treatment of Ocular Toxoplasmosis.
Ophthalmic Res. 2017;57(1):1-12. doi: 10.1159/000449169. Epub 2016 Oct 11.
3
Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography.
Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):2037-45. doi: 10.1007/s00417-013-2334-3. Epub 2013 Apr 9.
4
Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis.
Ophthalmology. 2011 Jan;118(1):134-41. doi: 10.1016/j.ophtha.2010.04.020. Epub 2010 Aug 12.
5
Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis.
J Clin Microbiol. 2008 Jun;46(6):1965-7. doi: 10.1128/JCM.01900-07. Epub 2008 Apr 9.
6
Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management.
Am J Ophthalmol. 2004 Jan;137(1):1-17.
7
The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis.
Am J Ophthalmol. 2002 Jul;134(1):41-6. doi: 10.1016/s0002-9394(02)01527-1.
8
Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis.
Am J Ophthalmol. 1999 Oct;128(4):413-20. doi: 10.1016/s0002-9394(99)00300-1.
9
Therapy for ocular toxoplasmosis.
Am J Ophthalmol. 1993 Apr 15;115(4):517-23. doi: 10.1016/s0002-9394(14)74456-3.
Zotero 插件